State Of Alaska, Department Of Revenue Eagle Pharmaceuticals, Inc. Transaction History

State Of Alaska, Department Of Revenue

$9.42 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$25.06 - $34.09 $3,032 - $4,124	-121 Reduced 1.67%	7,130 $202,000
Q4 2022 Jan 11, 2023	SELL	$24.98 - $39.77 $2,672 - $4,255	-107 Reduced 1.45%	7,251 $211,000
Q3 2022 Oct 20, 2022	SELL	$26.42 - $47.12 $28,824 - $51,407	-1,091 Reduced 12.91%	7,358 $194,000
Q2 2022 Jul 08, 2022	BUY	$41.26 - $51.35 $22,280 - $27,729	540 Added 6.83%	8,449 $375,000
Q1 2022 Apr 14, 2022	SELL	$44.58 - $52.6 $6,241 - $7,364	-140 Reduced 1.74%	7,909 $391,000
Q4 2021 Jan 12, 2022	SELL	$45.82 - $56.9 $16,495 - $20,484	-360 Reduced 4.28%	8,049 $409,000
Q3 2021 Oct 07, 2021	BUY	$43.79 - $55.78 $14,669 - $18,686	335 Added 4.15%	8,409 $469,000
Q2 2021 Jul 12, 2021	BUY	$36.86 - $44.5 $8,109 - $9,790	220 Added 2.8%	8,074 $345,000
Q1 2021 Apr 09, 2021	SELL	$40.32 - $50.97 $47,174 - $59,634	-1,170 Reduced 12.97%	7,854 $327,000
Q4 2020 Jan 08, 2021	SELL	$41.72 - $51.34 $95,956 - $118,082	-2,300 Reduced 20.31%	9,024 $420,000
Q3 2020 Oct 05, 2020	BUY	$37.02 - $51.28 $74,780 - $103,585	2,020 Added 21.71%	11,324 $481,000
Q2 2020 Jul 06, 2020	SELL	$43.24 - $55.02 $3,459 - $4,401	-80 Reduced 0.85%	9,304 $446,000
Q1 2020 Apr 06, 2020	BUY	$34.37 - $60.07 $59,975 - $104,822	1,745 Added 22.84%	9,384 $431,000
Q4 2019 Jan 07, 2020	SELL	$54.32 - $64.31 $7,170 - $8,488	-132 Reduced 1.7%	7,639 $458,000
Q3 2019 Oct 02, 2019	BUY	$53.25 - $59.98 $227,058 - $255,754	4,264 Added 121.59%	7,771 $439,000
Q2 2019 Jul 23, 2019	BUY	$46.61 - $58.45 $1,398 - $1,753	30 Added 0.86%	3,507 $195,000
Q1 2019 Apr 09, 2019	SELL	$38.66 - $51.82 $9,278 - $12,436	-240 Reduced 6.46%	3,477 $175,000
Q4 2018 Jan 10, 2019	BUY	$36.72 - $67.73 $4,039 - $7,450	110 Added 3.05%	3,717 $149,000
Q3 2018 Oct 09, 2018	BUY	$66.65 - $83.86 $60,318 - $75,893	905 Added 33.49%	3,607 $250,000
Q1 2018 Apr 19, 2018	BUY	$52.16 - $66.86 $52,681 - $67,528	1,010 Added 59.69%	2,702 $142,000
Q3 2017 Oct 16, 2017	BUY	$46.62 - $60.36 $78,881 - $102,129	1,692	1,692 $100,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account